Details for 2011168827
Up to date per 03.04.2026
Actions
Details for 2011168827
Granted/Registered
European Patent
14.09.2011 A
18.09.2013 B1
13.12.2005
GB
0525321
18.05.2006
GB
0609902
12.10.2006
GB
0620336
12.10.2006
GB
0620337
A61K 39/00 20060101AFI20110707BHEP
Owner
GlaxoSmithKline Biologicals S.A.rue de l'Institut, 89 1330 RixensartBE
Representative
Representative
SONN Patentanwälte GmbH & Co KGRiemergasse 141010 WienAT
Inventor
Vandepapeliere, PierreGlaxoSmithKline Biologicals S.A. Rue de l'Institut 89 B-1330 RixensartBE
Information about Fees